Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.601B
March 31, 2026 2.356B
December 31, 2025 1.508B
September 30, 2025 708.10M
June 30, 2025 692.00M
March 31, 2025 1.20B
December 31, 2024 2.054B
September 30, 2024 446.10M
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 750.00M
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 1.50B
December 31, 2021 750.00M
September 30, 2021 0.00
June 30, 2021 500.00M
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 500.00M
December 31, 2019 300.00M
September 30, 2019 600.00M
June 30, 2019 0.00
March 31, 2019 3.50B
December 31, 2018 1.10B
September 30, 2018 -659.70M
June 30, 2018 950.70M
March 31, 2018 1.10B
December 31, 2017 99.90M
September 30, 2017 0.00
June 30, 2017 199.90M
March 31, 2017 0.00
December 31, 2016 300.00M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 300.10M
December 31, 2015 252.90M
September 30, 2015 61.10M
June 30, 2015 124.90M
March 31, 2015 310.60M
December 31, 2014 300.00M
September 30, 2014 300.00M
June 30, 2014 145.00M
March 31, 2014 55.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Johnson & Johnson -138.00M
Merck & Co., Inc. 714.00M
Pfizer Inc. 0.00
Bristol Myers Squibb Co. 0.00
Atai Beckley, Inc. -2.625M